Royalty Pharma Reports First Quarter 2025 Results
NEW YORK, NY, May 8th, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts.
Keep up to date with all our latest financial information and events, and access our archives for historical data, presentations, statements and reports.